BioSpace News Archive

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today that it will release its third quarter 2019 financial results on Thursday, November 7, after the close of the U.S. financial markets

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced it has entered into a four-year debt facility with MidCap Financial (MidCap), the lead agent, and Silicon Valley Bank (SVB).

Audentes Therapeutics, Inc., a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases, will host a conference call and webcast to report its third quarter 2019 financial results and provide a corporate update on Thursday, November 7, 2019.

Nuvo Pharmaceuticals Inc., a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, announced its financial and operational results for the three and nine months ended September 30, 2019.

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the appointment of Veronica Jordan, Ph.D., to its Board of Directors, where she will serve as Chair of the Compensation Committee.

Series B investors include venture capital, industry, academia, patient advocacy groups and philanthropy

Reported Positive Phase 3 ClarIDHy Results for TIBSOVO® in Previously Treated IDH1 Mutant Cholangiocarcinoma; sNDA Submission Planned by Year-End

Antares Pharma, Inc. announced that it has received the final payment of $2.5 million from Ferring Pharmaceuticals in connection with the previously disclosed sale of Antares’ worldwide rights, including certain fixed assets, for the ZOMAJET™ needle-free auto injector device to Ferring.

Emerald Health Therapeutics, Inc. will participate in the Cowen 2nd Annual Boston Cannabis Conference being held on November 12th and 13th, 2019, at the InterContinental Boston..

TetraScience, developers of the industry’s first cloud-based data integration platform for life sciences R&D, announced it has secured a strategic investment from Waters Corporation, the world’s leading specialty measurement company.